# Smithkline Beecham (Smithkline Beecham Limited) Private limited company registered in London, classed under “Manufacture of basic pharmaceutical products” and 1 other activity. - Company number: 02337959 - Status: Active - Type: Private limited company - Incorporated: 24 January 1989 - Registered office: 79 New Oxford Street, London, WC1A 1DG - Location: London - Activity: Manufacture of basic pharmaceutical products ## Latest filed profit No profit figure in its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does Smithkline Beecham do? Private limited company registered in London, classed under “Manufacture of basic pharmaceutical products” and 1 other activity. ### How much turnover does Smithkline Beecham make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/smithkline-beecham-02337959 ### Is Smithkline Beecham profitable? Smithkline Beecham's profit isn't public: small companies may file without a profit and loss account. ### Who runs and owns Smithkline Beecham? Its directors are Victoria Anne Whyte, Robert William Butler, Edinburgh Pharmaceutical Industries Limited, Glaxo Group Limited. Its owners are shown to subscribers. ### Where is Smithkline Beecham based? Its registered office is 79 New Oxford Street, London, WC1A 1DG, in London. ### When was Smithkline Beecham founded? Smithkline Beecham Limited was incorporated on 24 January 1989. ### Is Smithkline Beecham still trading? The register lists Smithkline Beecham Limited as active. ## Timeline Recent filings and changes at Companies House. - 2026-07-26: Full accounts made up to 31 December 2025 - 2026-07-17: Appointment of Mr Robert William Butler as a director on 16 July 2026 - 2026-07-16: Termination of appointment of Dmytro Oliinyk as a director on 16 July 2026 - 2025-08-15: Full accounts made up to 31 December 2024 - 2024-09-23: Secretary's details changed for Mrs Victoria Anne Whyte on 11 September 2024 - 2024-09-22: Full accounts made up to 31 December 2023 - 2024-09-17: Director's details changed for Mr Dmytro Oliinyk on 11 September 2024 - 2024-09-11: Change of details for Glaxosmithkline Finance Plc as a person with significant control on 11 September 2024 - 2024-09-11: Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to 79 New Oxford Street London WC1A 1DG on 11 September 2024 - 2024-07-18: Register inspection address has been changed - 2023-08-22: Full accounts made up to 31 December 2022 - 2023-08-16: Director's details changed for Glaxo Group Limited on 6 June 2023 - 2022-08-05: Full accounts made up to 31 December 2021 - 2022-06-06: Resolutions (and 8 more like it since 27 October 2009) - 2022-06-06: Statement of company's objects - 2022-06-06: Memorandum and Articles of Association - 2022-03-10: Appointment of Mr Dmytro Oliinyk as a director on 19 February 2022 - 2022-03-09: Termination of appointment of Richard John Latchford as a director on 19 February 2022 - 2021-09-29: Full accounts made up to 31 December 2020 - 2021-09-29: Appointment of Mr Richard John Latchford as a director on 28 September 2021 - 2021-09-20: Termination of appointment of Erika Patteson-Brent as a director on 17 September 2021 - 2020-11-10: Termination of appointment of Ciara Martha Lynch as a director on 9 November 2020 - 2020-10-09: Full accounts made up to 31 December 2019 - 2020-09-04: Appointment of Mrs Erika Patteson-Brent as a director on 25 August 2020 - 2020-03-18: Appointment of Mrs Ciara Martha Lynch as a director on 2 March 2020 --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/smithkline-beecham-02337959